March 20th 2023
By Miranda Lankas
Pre- and post-menopausal patients with locally advanced or metastatic ER+/HER2- breast cancer with an ESR1 mutation are eligible to participate in the next round of Fablyn’s upcoming clinical trial.
March 20th 2023
Exercise, from walking to running, allows patients to take control of their bodies at a time when things may feel out of reach during their cancer journey.
March 20th 2023
By Natasha Carlson
I’ve met too many people who were told that they were too young for cancer before being diagnosed.
March 20th 2023
By Ronald Chin
I’m more than six years out from my myeloma diagnosis and realized that I’m capable of more than just surviving.
March 20th 2023
By Miranda Lankas
Watch Dr. Reshma Mahtani, from Miami Cancer Institute, Baptist Health South Florida, discuss clinical trial myths during the CURE Educated Patient® Breast Cancer Summit at MBCC.
March 20, 2023 7:00 PM
March 19, 2023 5:00 PM
March 18, 2023 3:00 PM
March 17, 2023 7:00 PM
March 20, 2023 3:00 PM
By Ronald Chin
March 17, 2023 9:00 PM
By Amy Larry
March 16, 2023 1:00 PM
By Janice Post-White
March 15, 2023 1:00 PM
By Tony O'Driscoll